Tyers Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $110K | Hold |
1,936
| – | – | ﹤0.01% | 830 |
|
|
2019
Q2 | $108K | Hold |
1,936
| – | – | ﹤0.01% | 838 |
|
|
2019
Q1 | $98K | Hold |
1,936
| – | – | ﹤0.01% | 844 |
|
|
2018
Q4 | $78K | Buy |
1,936
+374
| +24% | +$15.1K | ﹤0.01% | 837 |
|
|
2018
Q3 | $108K | Buy |
1,562
+132
| +9% | +$9.13K | ﹤0.01% | 858 |
|
|
2018
Q2 | $108K | Hold |
1,430
| – | – | ﹤0.01% | 824 |
|
|
2018
Q1 | $75K | Buy |
1,430
+242
| +20% | +$12.7K | ﹤0.01% | 896 |
|
|
2017
Q4 | $64K | Buy |
1,188
+220
| +23% | +$11.9K | ﹤0.01% | 922 |
|
|
2017
Q3 | $58K | Buy |
968
+286
| +42% | +$17.1K | ﹤0.01% | 913 |
|
|
2017
Q2 | $54K | Buy |
682
+374
| +121% | +$29.6K | ﹤0.01% | 909 |
|
|
2017
Q1 | $26K | Buy |
+308
| New | +$26K | ﹤0.01% | 928 |
|